This auto-inhibition mechanism is lost from the BCR-ABL protein, because the important N-terminal amino acid sequence in ABL is replaced by a sequence from the BCR gene, resulting in a constitutively active (i.e. constantly active) form of the kinase that causes cellular changes leading to leukaemia. This evidence concerns the gene BCR and leukemia.